Using Serum Advanced Glycation End Products-Peptides to Improve the Efficacy of World Health Organization Fasting Plasma Glucose Criterion in Screening for Diabetes in High-Risk Chinese Subjects

Step counter use in type 2 diabetes: a meta-analysis of randomized controlled trials

(2014) Shanhu Qiu et al.   BMC Medicine

Advanced glycation end products induce oxidative stress and mitochondrial dysfunction in SH-SY5Y cells

(2014) Xu Wang et al.   IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL

Impact of Walking on Glycemic Control and Other Cardiovascular Risk Factors in Type 2 Diabetes: A Meta-Analysis

(2014) Shanhu Qiu et al.   PLoS One

Prevalence and Control of Diabetes in Chinese Adults

(2013) Yu Xu   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Advanced oxidative and glycoxidative protein damage markers in the elderly with type 2 diabetes

(2013) Daniela Gradinaru et al.   Journal of Proteomics

Increasing Prevalence of Type 2 Diabetes in Chinese Adults in Shanghai

(2012) R. Li et al.   DIABETES CARE

Diet or diet plus physical activity versus usual care in patients with newly diagnosed type 2 diabetes: the Early ACTID randomised controlled trial

(2011) RC Andrews et al.   LANCET

Prevalence of Diabetes among Men and Women in China

(2010) Wenying Yang et al.   NEW ENGLAND JOURNAL OF MEDICINE

Dietary Advanced Glycation End Products and Aging

(2010) Claudia Luevano-Contreras et al.   Nutrients

Performance of an A1C and Fasting Capillary Blood Glucose Test for Screening Newly Diagnosed Diabetes and Pre-Diabetes Defined by an Oral Glucose Tolerance Test in Qingdao, China

(2009) X. Zhou et al.   DIABETES CARE

Prevalence and risk factors for type 2 diabetes mellitus in the Chinese adult population: The InterASIA Study

(2009) Dongsheng Hu et al.   DIABETES RESEARCH AND CLINICAL PRACTICE